Severe Euglycemic Diabetic Ketoacidosis Associated With SGLT2 Inhibitor

Carlos Mucharraz, MD

Anesthesiology Resident, CA-1
University of Colorado School of Medicine
Aurora

Luis A. Verduzco, MD

Staff Anesthesiologist
Denver Health Medical Center
Associate Professor
Department of Anesthesiology
University of Colorado School of Medicine
Aurora

Editor: Karen Sibert, MD

Introduction

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are one of the newest classes of oral diabetes medications.¹ The perioperative use of these medications has been associated with rare but serious adverse